Remove Bioinformatics Remove DNA Remove Science
article thumbnail

Improving viral vector safety for gene therapies

Drug Discovery World

Dr Andrea O’Hara, Senior Product Manager at Azenta Life Sciences asks why integration site analysis (ISA) is critical for the safety and efficacy of viral vectors for gene therapy. The enriched DNA is then sequenced. It is recommended to consider the relative advantages and disadvantages of each approach during study design.

Therapies 147
article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. Questions were fielded from the audience, which included: What analysis will be performed to evaluate host or other DNA contamination? Why are those important?

Therapies 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. Questions were fielded from the audience, which included: What analysis will be performed to evaluate host or other DNA contamination? Why are those important?

Therapies 130
article thumbnail

Drug discovery deals highlight key growth areas

Drug Discovery World

The acquisition of Olink underscores the profound impact that proteomics is having as our customers continue to advance life science research and precision medicine,” said Marc Casper, Chairman, President and Chief Executive Officer of Thermo Fisher.

DNA 130
article thumbnail

Twist Bioscience Harnesses AI-Powered Cloud for Synthetic Biology Breakthroughs

Fierce BioTech

The company has developed a disruptive DNA synthesis platform that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Listing Image oracle Listing Introduction Twist Bioscience’s DNA-based products are powering research to improve the lives of millions of people. Click here to login.

DNA 52
article thumbnail

Unlocking AI’s potential in drug discovery: A roadmap to scalable solutions

Drug Discovery World

The transformative power of AI While Foundation Models (FMs), including Large Language Models (LLMs) and image-based models, may not exhibit true intelligence, their potential to revolutionise fields like drug discovery and materials science is undeniable. Small Language Models (SLMs) are gaining traction, particularly in the life sciences.

Drugs 162
article thumbnail

Kickstarting the use of AI for biotechs: part two

Drug Target Review

2 AlphaFold 3 has been built to model DNA, RNA and smaller molecules (ligands). 5 Several major technology areas are not included above, such as cheminformatics and bioinformatics. Google DeepMind’s new AI can model DNA, RNA, and ‘all life’s molecules’. The latest exciting advancement is AlphaFold 3, which was just released.

RNA 59